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Abstract
Currently there is a need for new antibiotics with an alternative mode of action and new chemical structures. 
Bacterial pathogens are gradually becoming more resistant to conventional antibiotics, generating an emer-
gence of infectious diseases and they are becoming a great problem in the field of public health. In this study, 
seven different isolated bacteria were obtained from offshore seawater and sediment of the Gulf of Mexico from 
Campeche, Mexico. They were substance producers which inhibit growth of human pathogens like Staphylococ-
cus aureus and Pseudomonas aeruginosa and one of them was a polymer producer on peptone and glucose 
culture. They were characterized phenotipically by means of morphological techniques and physiologically by 
conventional tests. Four of them were Gram-positive bacteria and the Scanning Electron Microscope analysis 
revealed their size between 0.6 – 1.5 µm. One of seven marine strains, Gram negative, yellow pigmented, 
slightly curved rods, was identified as Pseudoalteromonas sp. on the analysis of the gen16S rRNA sequence.
Keywords: marine bacteria, marine antibiotic, Pseudoalteromonas, resistant pathogens.
Resumen
Hoy en día existe la necesidad de encontrar antibióticos con nuevas estructuras químicas y modos de acción 
alternativos. Se ha observado que bacterias patógenas comunes progresivamente desarrollan resistencia al 
tratamiento con antibióticos tradicionales, surgiendo y resurgiendo enfermedades infecciosas que generan 
un gran problema en salud pública. En este estudio, se obtuvieron siete colonias bacterianas pigmentadas de 
agua de mar y de sedimento marino procedente de las costas de Campeche, México. Las colonias aisladas 
produjeron sustancias que inhibieron el crecimiento de bacterias patógenas a humanos como Staphylococcus 
aureus and Pseudomonas aeruginosa. Las bacterias marinas fueron caracterizadas fenotípicamente de acuerdo 
a su morfología microscópica y por pruebas fisiológicas convencionales. Cuatro de los aislados resultaron 
ser bacterias Gram positivas y las otras tres fueron Gram negativas. Cuando se observaron por microscopía 
electrónica de barrido, su tamaño aproximado fue entre 0,6 – 1,5 µm. Uno de los aislados fue una colonia 
amarilla con bacilos cortos Gram negativos y ligeramente curvos, identificado por la secuencia del gen16S 
rRNA como Pseudoalteromonas sp. 
Palabras clave: bacteria marina, antibiótico, Pseudoalteromonas, patógenos resistentes.
Introduction
Currently emerging and reemerging infectious diseases are 
a major problem in public health and global economies. They 
are caused by different types of infections such as drug – resis-
tant infections, mostly involving bacteria, and many emerging 
pathogens are increasing significantly over time (Jones et al. 
2008) because they are becoming progressively more resistant to 
conventional antibiotic compounds. For example, Pseudomonas 
aeruginosa has been reported as an opportunistic pathogen and 
one of the most common causes of nosocomial infections by the 
intrinsic resistance to many antimicrobial agents (Kollef 2005, 
Depardieu et al. 2007). In Staphylococcus aureus, virulence and 
antibiotic resistance are contributing to its emergence as leading 
overall cause of nosocomial infections in both nosocomial and 
outside the hospital setting (Lowy 2003, Livermore 2004). 
Therefore, there is a need for a great variety of substances 
with antibiotic activity, a different mode of action and chemical 
structures. On the other hand, the chemical drugs synthesis has 
been a good option; however the diversity of microorganisms 
and their secondary metabolites is unrivaled and unmatched 
in medical significance (Fenical 1993). Microorganisms are 
a prolific source of structurally diverse bioactive metabolites 
and have yielded some of the most important products of the 
pharmaceutical modern industry (Cragg & Newman 2001). 
Although marine organisms do not have a significant history 
of use in traditional medicine, in the last years marine micro-
organisms have become an important point of study in search 
of novel microbial products showing antimicrobial activities, 
antiviral, immunosuppressives, enzyme inhibitor metabolites, 
receptor antagonists, antitumor activities and anticoagulant 
properties (Carte 1993, Jensen & Fenical 1994, Reichenbach 
2001). Marine natural products contain a wide range of novel 
antibiotics with unique complex structures not present in the 
terrestrial environment. The isolation of highly brominated 
compounds illustrates that marine bacterias have common me-
chanisms to incorporate bromine or other halogens into organic 
compounds that can potentially lead to enhance bioactivities 
(Bernan et al. 1997). 
Until recently, microbiologists were greatly limited in their 
studies of natural microbial ecosystems, because of disability 
to cultivate microorganisms out of their environment. Today, 
the bacterial growth from marine sediment takes place and it 
is well known (Kaeberlein et al. 2002) and procedures based 
in the extraction of nucleic acid from environmental samples 
have permitted the identification of microorganisms through 
the isolation and sequencing of ribosomal RNA o rDNA 
(Handelsman et al. 1998). Therefore, the recent development 
of procedures for cultivation and identifying microorganisms 
has aided microbiologists in their assessment of the earth’s full 
range of microbial diversity (Munn 2004). 
Their metabolic and physiological capacities allow microor-
ganisms to survive virtually across all environmental conditions 
found in the Earth. The adaptation of bacteria to diverse marine 
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habitat can determine the special skills for the production of 
unique secondary metabolites (Bernan et al. 1997). The micro-
organisms can even show properties different from terrestrial 
known species. For example the Gram positive marine halophilic 
bacteria Actinopolyspora AH1, isolated from the west coast of 
India, showed resistance or tolerance to some antibiotics and 
good antibacterial activities against Gram positive bacteria 
(Kokare et al. 2004).
In this work, seven strains were isolated from offshore 
seawater and sediment of the Gulf of Mexico from Campe-
che. They were substance-producers which inhibit growth of 
drug-resistant human pathogens like Staphylococcus aureus and 
Pseudomonas aeruginosa species. 
Material and methods 
Isolation and culturing of the microorganisms 
The microorganisms were obtained of seawater and sediment 
samples from the Gulf of Mexico, Campeche. Samples were 
collected 10 m of depth and 32 Km offshore, in November of 
2007. The salinity was 3,8% and the pH 8.0. The sediment 
and water samples were collected in sterile 50 mL conical tubes. 
Samples were kept cool during the expedition and processed as 
soon as possible until our return to the laboratory. 
Approximately 50 mg of wet sediment or 1 mL of seawater 
sample were used to inoculate agar plates supplemented with 2 
g.L-1 sodium caseinate, 0.1 g.L-1 asparagine, 0.001 g.L-1 ferrous 
sulfate and 0.075 g.L-1 ferric citrate dissolved in natural seawater. 
The final pH of the medium was adjusted to 8.0 before sterili-
zation. Agar medium was prepared with 100% natural seawater 
sterilized by filtration. The inoculated plates were incubated at 
28 oC for three weeks. After isolation, the colonies were purified 
by streak plate method and kept in 30% glycerol diluted in 
seawater-medium at –70 °C and recultured as required. 
Culture conditions.- The isolated colonies were cultured 
for 72 h in 50 mL of YPG medium, consisting of: 4 g.L-1 yeast 
extract; 5 g.L-1 casein peptone and 10 g.L-1 glucose; 2 g.L-1 
NaNO3; 0.01 g.L
-1 FeSO4; 0.5 g.L
-1 K2HPO4; 0.5 g.L
-1 MgSO4 
on filtered natural seawater and adjusted pH 8.0. These cultures 
were shaken at 150 rpm and 28 oC. Starter cultures were gene-
rated by inoculated 0.5 mL of subcultures from frozen culture 
(medium plus 30% glycerol) and grown under the same con-
ditions. The effect of the composition of the kind of water used 
for cultivation was determined using YPG medium dissolved in 
natural seawater, artificial seawater or distiller water.
Crude extract.- Marine bacterial cells were separated from 
the spent broth by centrifugation (at 3000 g for 15 min at 4 °C) 
and washed twice with sterile natural seawater. Two grams of 
biomass were resuspended in 10 mL of PBS and sonicated. Spent 
broth and crude extract was tested for antimicrobial activity.
Determination of antimicrobial activity
Antibacterial activity was tested against clinical pathogen 
which included: Gram positive bacteria Staphylococcus aureus 
ATCC 25923, Staphylococcus aureus S clinical isolate sensible 
to ampicillin (AM), ceftazidime (CAZ), cefataxime (CXM), 
gentamicin (GM) and Staphylococcus aureus R MRSA clinical 
isolate resistant to AM, GM, CAZ and Gram negative bacteria 
such as Pseudomonas aeruginosa R clinical isolate resistant to 
cefataxime (CTX),amikacin (AN). 
Paper disks impregnated with 20 μL of crude extracts or 
spent broth free of cells were used for antimicrobial activity 
assay using the conventional diffusion plate method. Inhibition 
zones around the disk indicated antibacterial activity which was 
measured after 24 h of incubation. Different antibiotics (ampi-
cillin (AM-10), ceftazidime (CAZ-30), vancomycin (VA-30), 
amikacin (AN-30), cefataxime (CTX-30), imipenem (IPM-10), 
cefurox (CXM-30), sulfamethoxazole with trimethoprim (SXT), 
gentamicin (GM-120) were used as positive or negative controls 
in the plates. For antibiotic sensitivity the isolated (MS-3/48) 
was tested on YPG agar in natural seawater plates and antibio-
tics IPM-10, CTX-30, AN-30, CF-30 from commercial BD 
BBLTM Sensi-DisksTM Antimicrobial Susceptibility Test Discs 
were used. The determinations were performed at least thrice 
and the averages of the values are reported.
Pigment extraction in acetone-methanol from strain (MS-
3/48).- We selected the isolated (MS-3/48)  and it was harvested 
by centrifugation. Yellow pigment was extracted from the cells 
with acetone-methanol (7:2 volume in volume) at 4 °C for 12 
h in dark (Du et al. 2006). After that the extract was evaporated 
off in vacuum below 30 °C. The concentrate extract was tested 
for antimicrobial activity bioassay and methanol (5%) was also 
used as a negative control.
Determination of cell dry weight.- A 25 mL amount of 
culture marine bacteria was filtered throughout 0.45 μm mem-
brane (millipore) under vacuum, the mass retained on the filter 
was washed with 25 mL of sterile natural seawater. The washed 
cells were dried in a microwave oven at constant weight and 
weighed. Every determination was performed at least twice and 
the averages of the values are reported.
Biochemical test.- Additional biochemical tests were carried 
out on one of seven isolates (MS-3/48) using API 20NE and 
API50 CH test kit (bioMérieux) as described by the manufac-
turer, with the exception that the strain was suspended in sterile 
natural seawater. 
PCR amplification of the 16S RNA gene
Amplification of the 16S ribosomal DNA (rDNA) sequence 
of strain MS-3/48 was carried out. First, 10 to 20 ng of purified 
genomic DNA was amplified in 50 μL of a reaction mixture 
consisting of 20 mM Tris-HCl (pH 8.4), 1,5 mM MgCl2, 200 
μM of each dNTP and 2 U of Taq DNA polymerase. The PCR 
primers used for amplification forward(5’ –CTYAAAKRAATT-
GRCGGRRRSSC- 3’ , E. coli positions 909-932) and reverse 
(5’ – CGGGCGGTGTGTRCAARRSSC - 3’ , E. coli positions 
1383 – 1404) at a final concentration of 0.2 μM as was described 
by Rivas (2004). PCR conditions were as follows: pre-heating 
at 95 oC for 5 min. The thermal profile consisted of 35 cycles of 
denaturing at 95 oC for 1 min; this was followed by an annealing 
step at 55 oC for 2 min and extension at 72 oC for 1 min, and 
a final extension at 72 oC for 7 min. 
The amplified product was checked by gel electrophoresis 
and a 400 bp DNA band was excised and purified using the 
DNA extraction kit Quiagen. The sequence reaction was per-
formed on a Perkin-Elmer Genetic Analyzer 310. The primers 
used were the same employed in the PCR amplification. The 
sequence obtained was compared against those in data bank 
using a BLAST program. 
233
 Marine bacteria isolated from Gulf of Mexico
Rev. peru. biol. 17(2): 231 - 236 (August 2010)
http://sisbib.unm
sm
.edu.pe/B
V
R
evistas/biologia/biologiaN
EW
.htm
Scanning electron microscopy
For scanning electron microscope, four isolates (named MS-
1/48, MS-3/48, MS-6/48 and MS-7/48) were fixed at 4 °C for 
1 h in 2.5% glutaraldehyde diluted in Millipore- filtered sea 
water, washed in the same water, post-fixed at 4 °C for 30 min 
in 1% OSO4 in sea water. The sample was filtered through a 
0.22-μ-pore-size filter. The filters were serially dehydrated with 
increasing ethanol concentrations (twice for 10 min in each 
stage) and dried at critical-point. The samples were mounted on 
scanning electron micrograph stubs, splatter coated with gold 
and viewed on a Zeeis DSM- 950 scanning electron microscope.
Results
Under isolation method evident growth of marine bacteria 
appeared on seawater agar plates after three weeks of incubation. 
During the course of screening for antimicrobial activity, 400 
marine strains were isolate and 48 (12%) showed to be pigmen-
ted strain. Seven (14.5%) out of 48 pigmented strains reveled 
antimicrobial activity against test bacteria as consequence only 
them were selected and named (MS-1/48, MS-2/48, MS-3/48, 
MS-4/48, MS-5/48, MS-6/48 and MS-7/48). Table 1 shows 
the antimicrobial activities from marine isolates bacteria. They 
showed to be substance-producers which inhibited growth of the 
bacteria pathogens S. aureus and P. aeruginosa. The marine stra-
ins, (MS-1/48), (MS-2/48), (MS-5/48) and (MS-6/48), showed 
a marked activity against Gram positive S aureus bacteria, but 
isolates (MS-3/48), (MS-4/48) and (MS-7/48) besides showed 
activity against Gram negative P. aeruginosa, although none of 
seven strains revealed activity against E. coli.
They were pigmented colonies and the strains (MS-1/48), 
(MS-2/48), (MS-6/48) and (MS-7/48) were Gram positive cells 
and the strains (MS-3/48), (MS-4/48) and (MS-5/48) were 
Gram negative cells (Table 2). 
When marine bacteria were grown in liquid YPG medium 
they exposed good growth after 48 h in presence of natural 
seawater or artificial seawater but non in YPG dissolved in 
distiller water.
Observations on light microscopy revealed that strain MS-
2/48 was rod-shaped and the strains (MS-4/48) and (MS-5/48) 
were coccus- shaped cells. Scanning electron microscopy of 
isolated (MS-1/48), (MS-3/48), (MS-6/48) and (MS-7/48) 
showed the general morphology of cells and size (Fig. 1). Cells 
from strains (MS-1/48) (1a) and (MS-3/48) (1b) confirmed to 
Figure 1. Scanning electron 
micrographs showing ge-
neral morphology of marine 
isolates. 
a) strain MS-1/48 x 10,000, 
b) strain MS-3/48 x 5,000, 
c) strain MS-6/48 x 10,000, 
d) strain MS-7/48 x 5,000.
Zone of inhibition (mm)a
Isolated
marine strains
S. aureus
ATCC 25923 
S. aureus Sb S. aureusc
MRSA
E. coli
ATCC 25922 P. aeruginosa S
d P. aeruginosa Re
MS-1/48 0 9 9 0 0 0
MS-2/48 0 10 12 0 0 0
MS-3/48 15 14 19 0 10 10
MS-4/48 12 13 13 0 9 8
MS-5/48 13 16 16 0 9 0
MS-6/48 20 17 16 0 9 0
MS-7/48 14 16 16 0 13 13
aDiameter of inhibitions zone; bClinical isolated sensible to AM, CAZ,CXM, GM; cClinical isolated resistant to AM, GM, CAZ; dClinical isolated sensible to CAZ; 
eClinical isolated resistant to CTX, AN
Table 1. Antimicrobial activity against reference human pathogen strains.
(a) (b)
(c) (d)
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be rod-shaped while cells strains (MS-6/48) (1c) and (MS-7/48) 
(1d) were coccus- shaped bacteria and ranged 0.65 to 1.5 μm 
in size. Besides, when isolated (MS-3/48) grew on glucose and 
peptone medium was polymer- producer and it was observed 
with SEM to bacterium encase in extracellular matrix material 
as shown in Figure 1b, similar to microorganims that grow in 
bofilms. 
Data of antimicrobial capacity against target bacteria were 
the criteria to select isolated (MS-3/48) for molecular analyses 
and API20 NE, API50 CH test.
The API20 NE test exhibited strain (MS-3/48) to be nitrate 
reductase negative, oxidase positive, citrate assimilation positive 
but weak glucose oxidation (Table 3). From 50 substrates and 
derivates only weak D-glucose utilization was observed in the 
API50 CH test (data not shown) and showed to be resistant to 
imipenem (IPM), cefalotina (CEP), amikacine (AMK) tests.
By separating the bacterial cells from the spent broth and the 
yellow pigment from the cells we were able to investigate the 
intracellular or extracellular antimicrobial activity. Crude extracts 
were prepared from sonicated biomass and then antimicrobial 
activity assay was performed indicating that antibiotic capacity 
resided in biomass but not in spent broth free of cells or in the 
pigment of cells (data not shown). 
In order to approach the genus to which the isolated cells 
could belong, we carried out 16S rRNA gene - PCR based 
method. When the BLAST was performed the sequence of 
the marine bacteria showed to be a part of bacterial species 
most closely related to Pseudoalteromonas sp. revealed 97% of 
similarity (Fig. 2). 
Discussion
Marine bacteria showing antibacterial activities have been 
described for more than 50 years (Rosenfeld & Zobell 1947). 
However, at present, the literature in México about microbial 
diversity of our coast is disperse or scarce particularly in relation 
to microorganisms producers of antimicrobial agents against 
Isolated 
marine 
strains
Pigment 
of strain
Gram 
stained Morphology
Sized (µm)
SEM
MS-1/48 Violet (+) Rod-shaped 1,08 – 1,48
MS-2/48 Red (+) Rod-shaped ND
MS-3/48 Yellow (-) Rod-shaped 0,6 – 1,5
MS-4/48 Pink (-) Coccus ND
MS-5/48 Pink (-) Coccus ND
MS-6/48 Pink (+) Coccus 0,83 – 1,48
MS-7/48 Pink (+) Coccus 0,65 – 1,0
Table 2. General morphology characteristics of isolated marine strains.
ND not determined
Pseudoalteromonas sp. LC5 16S rRNA gene, strain LC5
Bacterium SPE1 16S ribosomal RNA gene, partial sequence
marine bacterium P6 16S ribosomal RNA gene, complete sequence
marine bacterium O1 1 16S ribosomal RNA gene, complete sequence
Pseudoalteromonas sp. LS3 16S ribosomal RNA gene, complete sequence
uncultured bacterium isolate CWISO5 16S ribosomal RNA gene, parlial sequence
Pseudoalteromonas sp. A25 16S ribosomal RNA gene, partial sequence
Pseudoalteromonas sp. NJ6- 3- 1 16S ribosomal RNA gene, partial sequence
Pseudoalteromonas sp. O-79 16S ribosomal RNA gene, partial sequence
Bacterium K2- 890 16S ribosomal RNA gene, partial sequence
Pseudoalteromonas sp. X 153 16S rRNA gene, isolate X 153
marine bacterium PWF3 small subunit ribosomal RNA gene, partial sequence
Pseudoalteromonas sp. A22 16S ribosomal RNA gene, partial sequence
Pseudoalteromonas sp. A3 165 ribosomal RNA gene, partial sequence
Bacterium CWISO13 16S ribosomal RNA gene, partial sequence
P. piscicida 16S rRNA gene [ATCC 1 50 57]
Pseudoalteromonas piscicida gene for 16S ribosomal RNA, partial sequence, strain: 0-7
Pseudoalteromonas piscicida gene for 16S ribosomal RNA, parlial sequence, strain:IAm 129 32
Pseudoalteromonas sp. SOMBO50 partial 16S rRNA gene, isolate SOMBO 50
Pseudoalteromonas sp. GA S9 16S ribosomal RNA gene, complete sequence
Pseudoalteromonas sp. P12 16S ribosomal RNA gene, complete sequence
M93/C43
g-proteobacteria l 3 leaves
g-proteobacteria l 3 leaves
Figure 2. Dendogram of the relatedness of strain MS-3/48 with several Pseudoalteromonas species based on the 16S rDNA sequences. The 
Blast tree was constructed by neighbor joining analysis.
NO3 (-)
TRP (-)
GLU (+)
ADH (-)
URE (-)
ESC (+)
GEL (+)
PNG (-)
OX (+)
GLU A (+)
CIT A (+++)
Table 3. Conventional test (API 20NE) for MS-3/48 Gram negative.
(-) not growth; (+) weakly growth; (+++) good growth
NO3, potasic nitrate; TRP, L-tryptophane; GLU, D-glucose oxidation; ADH,L-
arginine; URE, Urea; ESC, ferric citrate esculin; GEL, gelatin; PNG, 4-nitrophenil-
D-galactopiranoside; OX, oxidase; GLU A, glucose assimilation; CIT A, citrate 
assimilation.
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human bacterial pathogens. In this study we have isolated and 
selected seven strains from offshore seawater and sediment in 
Campeche, México. They were Gram positive and Gram negative 
bacteria and showed antimicrobial activity against two bacteria 
reported as leading pathogen S. aureus and P. aeruginosa (Table 
1). Therefore, these antimicrobial marine agents could be an 
important therapeutic alternative particularly those directed 
against multiresistant Gram negative or Gram positive bacteria 
in hospitals. On the one hand, infections due to S. aureus are 
highly prevalent in pediatric patients and healing options are 
limited (Isnansetyo & Kamei 2003, Depardieu et al. 2007). On 
the other hand, Gram negative P. aeruginosa has been reported 
as one of the most common causes of nosocomial infections 
by the intrinsic resistance to almost all available antimicrobial 
agents (Livermore 2004, Kollef 2005, Depardieu et al. 2007). 
During antimicrobial spectrum determination from marine 
bacteria it was perceived that the Gram negative human bacte-
rial pathogens were not as susceptible to marine antagonists as 
were the Gram positive human bacterial pathogens; noted by 
inhibition zone against P. aeruginosa or E. coli, it was smaller 
than obtained against S. aureus as is shown in Table 1, a fact 
noted in accordance with the general observations made in 
marine microorganisms (Rosenfeld & ZoBell 1947, Saadoun 
et al. 1999, Basilio et al. 2003). 
Besides they confirmed their marine nature because the mari-
ne isolated did not expose growth in the YPG medium dissolved 
in distilled water which indicated the dependence on seawater. 
In this report, the seven isolates pigmented were bioactive 
compounds producer strains (Table 2). In accordance with this, 
it is a recognized fact that a likely association exists between 
pigments and toxic activity in several marine pigmented hetero-
trophic bacteria; for example, a number of biosynthetic enzymes 
involved in synthesis of inhibitors compounds were identified 
for pigment synthesis in Pseudoalteromonas tunicata (Lichstein 
& van de Sand 1945, Holmström et al. 1996, Egan et al. 2002). 
However, when we tested yellow pigment of strain (MS-3/48) 
against target pathogen bacteria, no antimicrobial activity was 
observed indicating that pigment was not the antimicrobial 
compound against target bacteria.
During observation with light and electron microscopes 
these marine bacteria were found to be coccus and rod-shaped 
cells and ranged from 0.65 to 1.5 μm of size (Figs. 1 a, b, c, d) 
according to dimensions of the representative marine prokar-
yotes (Munn 2004). 
On the other hand, some marine bacteria can also produce 
compounds as exopolymers to provide a means by which bac-
teria can adhere to surfaces and grow in biofilm (Holström & 
Kjelleberg 1999). We report a rod-shaped bacterium (strain 
MS-3/48) which was also producer of exopolymer as is shown 
in Fig. 1b. Our results may suggest that isolated MS-3/48 is 
biofilm-forming bacterium and its extracellular polymeric com-
pound helps the cell to avoid nutrient- depleted environments, 
which could enhance the chances for other marine organisms to 
survive in specific marine habitats as it was described for marine 
bacteria genus Pseudoalteromonas by Bowman (2007).
The crude extracts from biomass showed antibiotic activities 
against S. aureus and P. aeruginosa but non in pigment extracted 
from the cells or in the spent broth free of cells suggested that 
biological compounds with antimicrobial capacity were into 
the cells or it may be adhered to extracellular polymeric matrix 
close to the cells as describe in a marine Chromobacterium by 
Andersen et al. (1974). 
On the other hand, phenotypic analysis showed that the cells 
from isolated MS-3/48 were Gram negative bacteria, aerobic, rod 
shaped cells, 0.65 - 1 μm long, yellow pigmented cells, oxidase 
positive and nitrate reductase negative; sodium ions are essential 
for the growth of these cells. Moreover, it was characterized by 
hydrolisis of gelatine, citrate assimilation positive but weak 
glucose oxidation (Table 3) and it was resistant to imipenem 
(IPM), cefalotina (CEP), amikacine (AMK) test. In addition, 
the isolates (MS-3/48) observed some characteristics of marine 
bacteria genus Pseudoalteromona as gelatinase activity, weakly 
utilization of D-glucose and positive for oxidase as was reported 
by Ivanova et al. (2004) and Bowman, (2007). The 16S RNA 
gene sequence analysis and Blast queries against the latest release 
of the bacteria division of GeneBank ranged from 97% among 
Pseudoalteromonas sp. genus. In conclusion, mexican offshore 
may offer an opportunity of biological resource for antimicrobial 
therapeutic agents.
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